• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Albany Molecular Research Inc. (AMRI)

    -NasdaqGS
    20.60 Up 0.64(3.21%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 89,549   81,816   86,600   62,471  
    Cost of Revenue64,668  58,139  66,131  56,414  
    Gross Profit 24,881   23,677   20,469   6,057  
    Operating Expenses
    Research Development385  490  229  568  
    Selling General and Administrative16,696  17,856  14,297  11,828  
    Non Recurring1,632  4,102  3,031  3,396  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 6,168   1,229   2,912   (9,735)
    Income from Continuing Operations
    Total Other Income/Expenses Net634  469  (235)235  
    Earnings Before Interest And Taxes6,802  1,698  2,677  (9,500)
    Interest Expense3,178  3,036  2,704  2,575  
    Income Before Tax3,624  (1,338)(27)(12,075)
    Income Tax Expense1,317  885  1,834  (3,434)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops2,307  (2,223)(1,861)(8,641)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 2,307   (2,223) (1,861) (8,641)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 2,307   (2,223) (1,861) (8,641)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.